Inflammation-Associated Dysbiosis (IAD)

Sample type: Stool
Optimal result: 0 – 60 Level

An elevated Inflammation-Associated Dysbiosis (IAD) score suggests a significant imbalance in the composition of the gut microbiota, often associated with increased levels of inflammation within the gastrointestinal tract. This imbalance typically entails a reduction in beneficial or commensal bacteria and an increase in potentially harmful microorganisms.

The elevation of the IAD score indicates a dysbiotic state where the gut microbiome's composition deviates from its normal or healthy state. This dysbiosis may contribute to or exacerbate inflammatory conditions within the gut, such as inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS).

However, it's essential to interpret an elevated IAD score in conjunction with other clinical markers, such as inflammatory markers like fecal calprotectin, EPX, and sIgA, as well as the patient's symptoms and medical history. An elevated IAD score, along with elevated inflammatory markers, may suggest a stronger association between dysbiosis and inflammation, warranting further investigation and potentially targeted interventions to restore gut health.

The Inflammation-Associated Dysbiosis (IAD) score serves as a crucial metric for evaluating the interplay between gut inflammation and microbiota composition. This score holds significance as it illuminates how inflammation within the gastrointestinal tract impacts the delicate balance between beneficial and harmful gut bacteria.

Derived from a pattern-based algorithm, the Inflammation-Associated Dysbiosis score categorizes patients based on their scores, revealing a negative correlation between mean IAD score and commensal bacteria abundance, alongside positive associations with fecal calprotectin, EPX, and sIgA levels. Validation studies, encompassing Genova’s database of IBD patients and an independent UCLA study with IBD cohorts, underscore its reliability.

The causal relationship between inflammation-associated dysbiosis and inflammation remains uncertain. A low IAD score coupled with elevated inflammatory markers suggests that the gut microbiome might not be a contributing factor to the inflammatory condition, warranting exploration of alternative etiologies. Longitudinal investigations are imperative to unravel the implications of a high IAD score in the absence of elevated inflammatory markers. It's plausible that an inflammatory microbiome pattern may precede the onset of elevated inflammatory markers, underscoring the need for further research.

Genova’s data analysis has led to the development of unique dysbiosis patterns, related to key physiologic disruptions, such as immunosuppression and inflammation. These patterns may represent dysbiotic changes that could pose clinical significance.

The Inflammation-Associated Dysbiosis (IAD) score serves as a crucial metric for evaluating the interplay between gut inflammation and microbiota composition. This score holds significance as it illuminates how inflammation within the gastrointestinal tract impacts the delicate balance between beneficial and harmful gut bacteria.

Derived from a pattern-based algorithm, the Inflammation-Associated Dysbiosis score categorizes patients based on their scores, revealing a negative correlation between mean IAD score and commensal bacteria abundance, alongside positive associations with fecal calprotectin, EPX, and sIgA levels. Validation studies, encompassing Genova’s database of IBD patients and an independent UCLA study with IBD cohorts, underscore its reliability.

The causal relationship between inflammation-associated dysbiosis and inflammation remains uncertain. A low IAD score coupled with elevated inflammatory markers suggests that the gut microbiome might not be a contributing factor to the inflammatory condition, warranting exploration of alternative etiologies. Longitudinal investigations are imperative to unravel the implications of a high IAD score in the absence of elevated inflammatory markers. It's plausible that an inflammatory microbiome pattern may precede the onset of elevated inflammatory markers, underscoring the need for further research.

A decreased Inflammation-Associated Dysbiosis (IAD) score typically suggests a lower likelihood of dysbiosis or imbalance in the gut microbiota associated with inflammation in the gastrointestinal tract. This could indicate a healthier balance of beneficial and harmful bacteria in the gut, potentially reflecting a lower level of intestinal inflammation.

Here are some potential implications of a decreased/normal IAD score:

- Healthy Gut Microbiota: A lower IAD score may indicate a healthier composition of gut microbiota, with a higher abundance of beneficial or commensal bacteria and a lower abundance of harmful or pathogenic bacteria.

- Reduced Inflammation: It suggests that the gut microbiota may not be significantly contributing to inflammation in the gastrointestinal tract. This could be a positive indicator of lower levels of intestinal inflammation.

- Potential Normal Functioning: In some cases, a decreased IAD score may suggest that the gut microbiota is functioning within normal parameters and not driving inflammatory processes.

However, it's essential to interpret the IAD score in conjunction with other clinical parameters and individual health contexts. While a decreased IAD score may be indicative of a healthier gut microbiota and reduced inflammation, other factors contributing to gastrointestinal health should also be considered for a comprehensive assessment.

Inflammation-Associated Dysbiosis (IAD)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Inflammation-Associated Dysbiosis (IAD) — 10,000+ markers explained
One Inflammation-Associated Dysbiosis (IAD) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro